We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CRBP market cap is 120.58M. The company's latest EPS is USD -3.6621 and P/E is -2.69.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.49M | -10.1M | -9.62M | -10.99M | -15.51M |
| Net Income | -10.05M | -8.02M | -6.9M | -10M | -13.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.14M | 3.94M | 882k | 0 | 0 |
| Operating Income | -77.1M | -122.81M | -55.99M | -39.84M | -45.08M |
| Net Income | -71.45M | -111.27M | -45.64M | -42.35M | -44.6M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.28M | 28.27M | 125.74M | 151.98M | 164.17M |
| Total Liabilities | 35.97M | 35.18M | 28.78M | 26.44M | 13.67M |
| Total Equity | 311k | -6.91M | 96.97M | 125.54M | 150.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 49.14M | 102.3M | 107.73M | 66.31M | 28.27M |
| Total Liabilities | 42.98M | 57.02M | 38.62M | 33.32M | 35.18M |
| Total Equity | 6.16M | 45.28M | 69.11M | 32.99M | -6.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.09M | -36.1M | -7.97M | -16.91M | -30.85M |
| Investing | 25.25M | 35.64M | -98.24M | -114.68M | -130.04M |
| Financing | -916k | -2.82M | 106.58M | 141.55M | 166.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.72M | -99.69M | -48.18M | -37.54M | -36.1M |
| Investing | -2.74M | -485k | -73.42M | 30.07M | 35.64M |
| Financing | 38.47M | 154.88M | 60.82M | -534k | -2.82M |
| Market Cap | 120.58M |
| Price to Earnings Ratio | -2.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.73 |
| Price to Book Ratio | -17.36 |
| Dividend Yield | - |
| Shares Outstanding | 12.18M |
| Average Volume (1 week) | 207.48k |
| Average Volume (1 Month) | 201.97k |
| 52 Week Change | -60.24% |
| 52 Week High | 61.90 |
| 52 Week Low | 9.806 |
| Spread (Intraday) | 0.05 (0.5%) |
| Company Name | Corbus Pharmaceuticals Holdings Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.corbuspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
